May 2025 Archive — Practical drug guides: Lamisil, antidepressant options, hepatitis, and AFib blood thinners

This month we focused on four real-world topics that change day-to-day care: how to use Lamisil safely, what to try when Wellbutrin SR isn’t enough, the key differences between chronic hepatitis B and C, and clear comparisons of apixaban versus edoxaban for AFib. Each piece is short, practical, and made to help you ask better questions at your next clinic visit.

Lamisil (terbinafine): what to expect and smart use

Our Lamisil guide explains when to use topical creams vs oral tablets, and why nail infections often need months of treatment. For athlete’s foot or ringworm, a topical product for 1–2 weeks usually works; for nail fungus, oral terbinafine often gives the best results but requires a longer course and a liver check. Watch for common side effects — stomach upset, headache, and changes in taste — and be alert for signs of liver trouble: jaundice, dark urine, and severe fatigue. Simple tips: follow the full course, avoid heavy alcohol while taking oral terbinafine, and tell your doctor about any liver disease or other meds you take.

When Wellbutrin SR fails: stronger options explained

If bupropion (Wellbutrin SR) isn’t controlling symptoms, the article breaks down three practical pathways: switch to a different single antidepressant class (for example an SNRI), try an antidepressant with a different receptor profile, or consider augmentation strategies (adding a low-dose atypical antipsychotic or mood stabilizer under close supervision). We compare speed of effect, typical side effects, and what recent comparative trials say about response rates. The short takeaway: there’s no one-size-fits-all upgrade — discuss side effects you can tolerate, how fast you need relief, and any medical history with your prescriber before switching.

Also this month: a clear, reader-focused explainer on chronic hepatitis B versus hepatitis C. Hep B is preventable with a vaccine and spreads through blood, sex, and birth; hepatitis C spreads mainly through blood contact and is now curable in most people with direct-acting antivirals. Both can cause cirrhosis and liver cancer, so testing and early treatment choices matter.

Finally, our AFib piece compares apixaban and edoxaban as modern alternatives to warfarin. Both are direct oral anticoagulants (DOACs) with fixed dosing and fewer food interactions. Apixaban has large trial data showing lower stroke and bleeding risk compared with warfarin in many patients; edoxaban is non-inferior to warfarin and can have lower major bleeding in some groups. Key practical points: check kidney function before choosing a DOAC, adjust dose when needed, and never stop anticoagulation suddenly without medical advice. Carry treatment info for emergency visits.

Want details? Click into any post to read step-by-step advice, side-effect checklists, and questions to bring to your clinician. These reads are written for everyday decisions — clear, practical, and focused on what actually helps you get better care.